BT has been innovating for 170 years to help bring people closer together, create new possibilities and change lives…and we’re not stopping now. We’re the third largest investor in research and development in the UK in the last 10 years. We invested £2.8 billion in just 5 years and over £502 million in 14/15 alone.
Our researchers, scientists and engineers work together with academic partners, government bodies, start-ups, telcos and key customers, to shape the way we use technology.
We also have an innovation scouting team who are out scouring the world for brand new technologies, trends in the market and game changing ideas. This team alone magnifies our innovation capabilities by x 1000.
This unique breadth of scope, reach and capability helps us to solve even the most complex business communications requirements on a global scale. Which is why customers in the UK and more than 170 countries worldwide trust us to deliver world-class communications.
Our ambition is to position Britain as a leading digital society as we continue to push the boundaries of technology innovation. We believe that the key to achieving this is always asking ‘what if…’
Visit us on stand C2 to find out how our innovations are bringing people and technology together to make the digital possible.
We are a science-led global healthcare company with a mission: we want to help people to do more, feel better, live longer.
The vaccines, medicines and consumer healthcare products that we research and develop can improve people’s health and well-being, ultimately helping them to live life to its fullest and contribute to the prosperity of their communities.
We ask all of our employees to share our mission and consider how what they do can help all those people who rely on the products we make. It is why every day our scientists search for new ways to improve the treatment of diseases and illnesses. And it is why we have been pioneering new solutions that allow us to make our products available to those who need them, wherever in the world they live and whatever their ability to pay.
We are a business, so we need to do this in a sustainable way. But in doing this well, we deliver a profitable and sustainable performance. This in turn allows us to generate value and returns for our shareholders, while maintaining the substantial investment we make into the research and discovery, manufacturing, supply and distribution of our products that ultimately delivers value to patients and society.
Johnson & Johnson Innovation, LLC, with centers in London, Boston, California and Shanghai, focuses on accelerating early stage innovation worldwide, forming collaborations between entrepreneurs and J&J’s global healthcare businesses and facilitate collaborations across the pharmaceutical, medical device and diagnostics and consumer companies of J&J. By working together in new and creative ways, we will advance innovative healthcare solutions that deliver value and improve people’s lives around the world.
Manchester Airport is the third biggest in the UK, handling more than 23.5 million passengers a year and more than 100,000 tonnes of freight. It serves a catchment area covering more than a third of the UKs population, with flights to more than 210 destinations. In many cases, it is the only UK airport outside of London offering flights to key global markets. These include Abu Dhabi, Qatar, Hong Kong, Beijing, Singapore and numerous destinations on both the east and west coasts of America. In the coming months San Francisco, a key route for the technology and biomedical sectors of the North, will also commence thus reaffirming Manchester's position as the global gateway for the North of England.
There are more than 22,000 people employed on site at Manchester Airport, with 45,000 jobs supported directly and indirectly and the airport contributes £1.7bn of Gross Value Added (GVA) to the UK economy each year. These figures are only set to increase with the £800m Airport City Manchester project. This aims to leverage the airports worldwide connectivity to attract global businesses to the UK and will create more than 10,000 jobs in the coming years.
This year also sees the start of works on the airports £1bn 10-year transformation programme. The project will overhaul the airports terminals and reconfigure its airfield to create a state-of-the-art and world-leading facility. Crucially, the scheme will unlock the airports growth potential, making it possible to handle up to 45 million passengers a year.
Manchester Science Partnerships (MSP) is home to a community of scientists, innovators, investors and entrepreneurs. MSP actively supports science, technology and innovation companies of all sizes by providing access to finance, talent, markets, networks and investors to accelerate and support business growth.
MSP is the largest science and technology park operator in the UK, with five sites across the North West of England, offering everything from incubation centres to bespoke build laboratories and state of the art office space.
MSP’s largest campus, Alderley Park, holds an international reputation for drug discovery and development amongst the biotech and life science sector. An open-innovation community, it is not only home to a cluster of small, medium and large businesses from around the globe but it is also the home of Innovate UK’s Medicines Discovery Catapult, the UK Government’s translational centre for AMR and has a large talent pool of experienced scientists.
In the heart of Manchester’s innovation district, Citylabs 1.0, a biomedical centre of excellence brings together biotech, medtech and medical R&D companies that are changing the future delivery of patient treatment and care.
MSP is anchored by a strong set of partnerships from across the health, science and technology sectors including The University of Manchester, Manchester Metropolitan University, Central Manchester University Hospitals NHS Foundation Trust, Manchester City Council, Northern Health Science Alliance, Health Innovation Manchester, N8 and industry bodies such as BioNow and the BIA.
It is these partnerships and connections that means more businesses based at MSP sites survive, grow, thrive and succeed than the local or national average.
Siemens, the leading global engineering and technology services company, has been active in the United Kingdom for over 170 years. We provide innovative solutions to help tackle the UK’s major challenges. Siemens has a significant presence throughout the UK, with 13 manufacturing sites and more than 25 major offices.
We are a global charitable foundation dedicated to achieving extraordinary improvements in human and animal health. We support the brightest minds in biomedical research and the medical humanities. Our breadth of support includes public engagement, education and the application of research to improve health. We are independent of both political and commercial interests.
KPMG is proud to be a Principal Partner of ESOF 2016 and a supporter of Manchester as European City of Science.
As one of the UK’s leading professional services organisations, we are passionate about the Manchester city region and are immensely proud to have worked closely with the ESOF leadership team in bringing the EuroScience Open Forum to the North West.
It is our firm belief that if we are to create a Northern Powerhouse that is vibrant, progressive and powerful on a global stage, then science and innovation has to be at its core.
If we want to attract and retain the brightest talent to the city – the best engineers, the best innovators, the best manufacturers - then science needs to be at its very heart.
If we want our universities to continue to be at the forefront of discovery and cutting-edge learning, then investment in research and development must continue to be made.
With more than 4,500 visitors expected to descend on Manchester during the Festival, ESOF 2016 will confirm Manchester’s status as the UK’s foremost scientific hub.
We look forward to an exciting and successful year ahead.
Manchester's unique scientific history and dedication towards industry and innovation makes it the perfect home to welcome ESOF 2016 and we are proud to be a part of this. Based in the heart of Manchester and with our commitment to the city, ESOF provides a fantastic opportunity to help shape conversations on science, health, innovation and technology and the implications these could have on both Manchester's and Europe's future economies.
Our interest in this runs deep, as it does for many of our clients. We are excited at the prospect of building new relationships not only from the global and European scientific community but also to meet other stakeholders involved with the programme and next generation thinking. Our involvement in the Science to Business aspects of ESOF connects us directly with industry leaders and leading academics, placing us at the centre of the explorations of issues surrounding breakthroughs in science. We will be sharing ideas and looking at ways we can improve commercial outcomes from scientific innovations over the coming months, which is at the core of all that we do for our clients.
Ultimately, we help our clients respond to change, anticipate future developments and be ready to maximise opportunities as and when they arise. A real meeting of minds.
Waters Corporation, the premium brand in the analytical instruments industry, creates business advantages for laboratory-dependent organizations by delivering practical and sustainable scientific innovation to enable significant advancements in healthcare delivery, environmental management, food safety, and water quality worldwide. Bringing keen understanding and deep experience to those responsible for laboratory infrastructure and performance, Waters helps customers make profound discoveries, optimize laboratory operations, deliver product performance, and ensure regulatory compliance. Pioneering a connected portfolio of separations and analytical science, laboratory informatics, mass spectrometry, as well as thermal analysis, Waters’ technology breakthroughs and laboratory solutions provide an enduring platform for customer success.
Nature is the world's foremost international weekly scientific journal and is the flagship journal for Springer Nature. It publishes the finest peer-reviewed research in all fields of science and technology on the basis of its originality, importance, interdisciplinary interest, timeliness, accessibility, elegance and surprising conclusions. Nature’s landmark papers, award winning news, leading comment and expert opinion on important, topical scientific news and events enable readers to share the latest discoveries in science and evolve the discussion amongst the global scientific community.
Unilever is one of the world’s leading suppliers of Food, Home and Personal Care products with €53 billion Turnover in over 190 countries, reaching 2 billion consumers a day. 58% of the company’s footprint is in developing and emerging markets. Unilever has more than 400 brands, including Persil, Domestos, Axe, Dove, Knorr, Hellmann’s, Lipton, Ben & Jerry’s and Magnum.
Unilever’s Sustainable Living Plan (USLP) commits to:
- Decoupling growth from environmental impact.
- Helping more than a billion people take action to improve their health and well-being.
- Enhancing the livelihoods of millions of people by 2020.
EuroScientist is the official journal of EuroScience, a grassroots association of scientists and people with an interest in science-related matters in Europe. We mainly focus on issues arising at the interface with society in Europe, including science policy. Our vision is to ensure that EuroScientist reflects the diversity of voices of scientists and those working in fields related to science and on matters related to European research. Its motto is: “European science conversations by the community, for the community.” It is a magazine designed to enable members of the European science community and others, including policy makers, to share opinions and perspectives on current issues. It also aims, to a large extend, at furthering the debate on topical issues.
Insight is a leading European publishing company specialising in the communication of science, research and innovation. With its popular news site and influential magazine Projects, Insight works with leading scientists, researchers and innovators to help bring their work to life and ensure it creates meaningful impact to a variety of audiences. Insight adopts a multi-media approach to this communication, finding the right medium for each story. As well as delivering cutting edge editorial products, Insight also provides bespoke dissemination services to research projects and organisations, often involved at the proposal stage to ensure impact is given the highest priority.
New Scientist is a weekly science and technology magazine read by over 770, 000 people worldwide each week. Featuring a selection of the latest news stories from the world of science and technology, alongside in-depth features exploring the latest ideas that affect the world and how we understand it, reviews of the latest culturally relevant books, films or art and stunning imagery from around the world and beyond. New Scientist Jobs is the online resource for the best jobs, careers advice and candidates in STEM, which attracts over 145 000 active STEM jobseekers each month.
Research Europe is the leading independent newsletter on European research policy. It provides a genuinely independent and critical news perspective on European Union research programmes, as well as other research policy news from national agencies, universities, laboratories and lobby groups throughout Europe.
SciDev.Net is the world’s leading source of reliable and authoritative news, views and analysis on information about science and technology for, from and by the global South. We bring science and development together through original journalism, including multimedia and data visualisation. SciDev.Net’s mission is to help individuals and organisations apply evidence and innovations from science and technology to decision-making to assist equitable and sustainable development and poverty reduction.
Texere Publishing is a UK-based publishing company that develops cutting-edge and global-leading publications for professionals in the scientific, healthcare and medical fields. Our publications are truly innovative and push the boundaries of reporting; telling the real-life, often controversial, stories of the people at the beating heart of their profession, and reporting on the innovations that will shape their future. Our titles include: The Analytical Scientist, The Translational Scientist, The Pathologist, The Medicine Maker, and The Ophthalmologist.
Copernicus, the European Union’s flagship for climate and atmospheric analysis: At our exhibition stand we provide an overview of how Copernicus is equipping society, policy-makers and industry to mitigate climate threats, adapt to change and capitalise on opportunities.
COST (European Cooperation in Science and Technology) is a pan-European intergovernmental framework. Its mission is to enable breakthrough scientific and technological developments leading to new concepts and products and thereby contribute to strengthening Europe’s research and innovation capacities.
It allows researchers, engineers and scholars to jointly develop their own ideas and take new initiatives across all fields of science and technology, while promoting multi- and interdisciplinary approaches.
Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions — among them ScienceDirect, Scopus, Elsevier Research Intelligence and ClinicalKey — and publishes nearly 3,800 journals, including The Lancet andCell, and over 35,000 book titles, including a number of iconic reference works.
La Caixa Banking Foundation
The commitment to build a better future
”la Caixa” Foundation works, year after year, to launch social initiatives to attend to those most in need, investing in the future of young people through education and promoting culture and science so that they are accessible to everyone.
This commitment to society has established ”la Caixa” Foundation as the Spanish leading foundation and third in the world.